Long-term prognostic role of functional limitations among women with breast cancer

Journal of the National Cancer Institute

Volumn 102, Issue 19, 2010, Pages 1468-1477

  Braithwaite, Dejana ^a   Satariano, William A ^b   Sternfeld, Barbara ^c   Hiatt, Robert A ^a   Ganz, Patricia A ^d   Kerlikowske, Karla ^a   Moore, Dan H ^a   Slattery, Martha L ^e,f   Tammemagi, Martin ^g   Castillo, Adrienne ^c   Melisko, Michelle ^a   Esserman, Laura ^a   Weltzien, Erin K ^c   Caan, Bette J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

^g BROCK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ANGINA PECTORIS; ARTHRITIS; ARTICLE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; DIVERTICULITIS; EDUCATIONAL STATUS; ENDURANCE; FOLLOW UP; FUNCTIONAL STATUS; GALLBLADDER DISEASE; HUMAN; HYPERTENSION; IRRITABLE COLON; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MUSCLE STRENGTH; OBESITY; OSTEOPOROSIS; OVERALL SURVIVAL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANGE OF MOTION; SEX DIFFERENCE; SMOKING; STROKE; ULCER; UNITED STATES; AGE; BREAST TUMOR; CANCER STAGING; CLINICAL TRIAL; DAILY LIFE ACTIVITY; EPIDEMIOLOGY; FEMALE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; RISK; RISK FACTOR; TIME;

ACTIVITIES OF DAILY LIVING; ADULT; AGE FACTORS; AGED; BODY MASS INDEX; BREAST NEOPLASMS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LIFE STYLE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SAMPLING STUDIES; TIME FACTORS; UNITED STATES;

EID: 77957835496     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq344     Document Type: Article

References (44)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-1717.
2. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758-2765.
3. Hewitt ME, Greenfeld S, Stovall E. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: The National Academies Press; 2005.
4. Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007;19(1):31-36.
5. Henderson IC, Patek AJ. The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res Treat. 1998;52(1-3):261-288.
6. Rowland JH, Yancik R. Cancer survivorship: the interface of aging, comorbidity, and quality care. J Natl Cancer Inst. 2006;98(8):504-505.
7. Given B, Given C, Azzouz F, Stommel M. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res. 2001;50(4):222-232.
8. Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16(4):1582-1587.
9. Sweeney C, Schmitz KH, Lazovich D, Virnig BA, Wallace RB, Folsom AR. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst. 2006;98(8):521-529.
10. Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol. 2004; 22(10):1849-1856.
11. Hudis CA, Barlow WE, Costantino JP, et al. Proposal for standardized defnitions for effcacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol. 2007;25(15):2127-2132.
12. Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol. 2010;28(3):380-386.
13. Chapman JA, Meng D, Shepherd L, et al. Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst. 2008;100(4):252-260.
14. Polednak AP. Racial differences in mortality from obesity-related chronic diseases in US women diagnosed with breast cancer. Ethn Dis. 2004;14(4): 463-468.
15. Carmichael AR. Obesity and prognosis of breast cancer. Obes Rev. 2006;7(4):333-340.
16. Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DS. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst. 2008;100(23):1724-1733.
17. Satariano WA, Ragland DR, DeLorenze GN. Limitations in upper-body strength associated with breast cancer: a comparison of black and white women. J Clin Epidemiol. 1996;49(5):535-544.
18. Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML. Life After Cancer Epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control. 2005; 16(5):545-556.
19. Jette AM, Branch LG. The Framingham Disability Study: II. Physical disability among the aging. Am J Public Health. 1981;71(11):1211-1216.
20. National Institute on Aging. Established Populations for Epidemiologic Studies of the Elderly.Washington, DC: National Institute on Aging; 1986.
21. Nagi SJ. An epidemiology of disability among adults in the United States. Milbank Q. 1976;54:439-468.
22. Rosow I, Breslau N. A Guttman health scale for the aged. J Gerontol. 1966;21(4):556-559.
23. Satariano WA, Ragland DR. Upper-body strength and breast cancer: a comparison of the effects of age and disease. J Gerontol A Biol Sci Med Sci. 1996;51(5):M215-M219.
24. Tager IB, Hollenberg M, Satariano WA. Association between self-reported leisure-time physical activity and measures of cardiorespiratory ftness in an elderly population. Am J Epidemiol. 1998;147(10):921-931
25. Expert Panel on the Identifcation, Evaluation, and Treatment of Overweight and Obesity in Adults. Executive summary of the clinical guidelines on the identifcation, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158(17):1855-1867.
26. Staten LK, Taren DL, Howell WH, et al. Validation of the Arizona Activity Frequency Questionnaire using doubly labeled water. Med Sci Sports Exerc. 2001;33(11):1959-1967.
27. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(suppl 9):S498-S504.
28. Fleming ID, Cooper JS, Henson DE. AJCC Cancer Staging Manual. 5th ed. New York, NY: Lippincott-Raven; 1997.
29. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765-1772.
30. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
31. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34(1):73-84.
32. Braithwaite D, Tammemagi CM, Moore DH, et al. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009;124(5):1213-1219.
33. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79(3):340-349.
34. Cox DR, Oakes D. Analysis of Survival Data. Monographs in Statistics and Applied Probability 21. Gainesville, Florida: Chapman and Hall; 1994.
35. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. Statistics for Biology and Health. New York, NY: Springer-Verlag; 2000.
36. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515-526.
37. Reuben DB, Rubenstein LV, Hirsch SH, Hays RD. Value of functional status as a predictor of mortality: results of a prospective study. Am J Med. 1992;93(6):663-669.
38. Scott WK, Macera CA, Cornman CB, Sharpe PA. Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol. 1997;50(3):291-296.
39. Satariano WA, Ragheb NE, Branch LG, Swanson GM. Diffculties in physical functioning reported by middle-aged and elderly women with breast cancer: a case-control comparison. J Gerontol. 1990;45(1):M3-M11.
40. Brinkley TE, Leng X, Miller ME, et al. Chronic infammation is associated with low physical function in older adults across multiple comorbidi-ties. J Gerontol A Biol Sci Med Sci. 2009;64(4):455-461.
41. Demark-Wahnefried W, Pinto BM, Gritz ER. Promoting health and physical function among cancer survivors: potential for prevention and questions that remain. J Clin Oncol. 2006;24(32):5125-5131.
42. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82(5):703-710.
43. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol. 1999;17(5):1442-1448.
44. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56(3):168-183.